The KDM3B gene helps control when other genes are turned on or off, which supports normal growth and early development. This gene plays an important role in how the brain and other tissues mature. If the KDM3B gene does not work properly, it can cause a genetic condition linked with developmental delay, learning difficulties, short stature, and facial features that doctors may recognize. KDM3B is mainly known in genetics clinics and research rather than through a widely known public story.
What is a gene?
Within DNA, a gene is a stretch that gives your cells instructions to make molecules or direct processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do the work. Other genes mostly regulate when certain processes happen, where they happen, and how active they are. As a whole, genes affect how the body develops and works, and they can influence how you react to food, stress, or medications. To go into this topic in more detail, you can find more in LearnHub.
Overview
KDM3BGene function
What if the gene works
The KDM3B gene helps control which genes turn on or off by adjusting how DNA is packaged. This supports normal cell growth, development, and the healthy formation of blood cells.
Risk
What if the gene does not work
Variants that reduce activity of the KDM3B gene can cause a neurodevelopmental condition with delayed development, learning difficulties, short stature, and distinctive facial features. Milder or more severe variants may influence which features appear and how strongly they affect someone.
Treatment
What does that mean for your treatment
No treatment or management approach is currently tailored specifically to pathogenic variants in the KDM3B gene. Variants in this gene are being studied in cancer and cell growth research as possible biomarkers or drug targets, but this has not led to guideline supported treatment choices.
Conditions associated with KDM3B
Gene function
What if the gene works
Your cells constantly decide which instructions to use and which to keep quiet. The KDM3B gene helps manage that balance by adjusting small chemical marks on DNA packaging proteins. Understanding what the KDM3B gene does helps explain how cells keep gene activity orderly over time.
The KDM3B gene helps remove small chemical tags from histones, the proteins that DNA wraps around. This can open tightly packed DNA so the cell can reach certain genes more easily.
By changing these tags, this gene helps cells decide which instructions to read and when to read them. This supports steady day to day control of many genes instead of switching everything on at once.
KDM3B works with other proteins in the nucleus, the cell’s control center, to guide normal patterns of gene activity. This helps cells follow the right program as they grow, mature, and carry out routine tasks.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the KDM3B gene can weaken or switch off the protein, making it harder for cells to remove chemical tags from proteins that package DNA and to control which genes are active. This is how KDM3B variants affect gene function in cells. Milder variants may leave some activity, while more severe variants can cause a larger loss of function. In Diets-Jongmans syndrome, that difference may influence which features appear and how strongly they show.
How variants are linked to conditions
Pathogenic variants in the KDM3B gene cause Diets-Jongmans syndrome, a genetic condition linked with developmental delay, learning difficulties or intellectual disability, short stature, and characteristic facial features. Some people with this KDM3B-related condition also have feeding difficulties, low muscle tone, behavior differences, or hearing and vision concerns. In this setting, finding a disease-causing KDM3B variant can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, however, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is no broadly confirmed evidence that specific lifestyle or environmental factors increase or reduce health risks related to the KDM3B gene. For many living with a disease-causing KDM3B change, the main factor is the genetic change itself, while family history can affect the chance of it occurring in relatives.
Inheritance of KDM3B variants
For the condition most clearly linked to the KDM3B gene, the KDM3B inheritance pattern is autosomal dominant. This means a person can develop the condition with one altered copy of the gene, and an affected parent has a 50% chance of passing it on to each child. Some people have the variant for the first time as a new, de novo change, so it was not inherited from either parent. Sons and daughters can inherit it equally.
What does my KDM3B result mean for my family?
For KDM3B, the main known condition is usually passed on in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change. In many families, the change happens for the first time in one person, so a parent may not have it. The meaning for relatives depends on the exact result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
KDM3B genetic testing usually uses a blood or saliva sample, and DNA sequencing looks for changes in the KDM3B gene that may help explain developmental or learning differences. To find out about KDM3B variants, clinicians often use exome sequencing or a multigene panel, and the lab reports whether a variant is pathogenic, likely pathogenic, benign, or of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the KDM3B gene may be considered when a child has developmental delay, speech delay, intellectual disability, short stature, or other features that suggest an inherited condition. It can also help confirm a KDM3B-related diagnosis when a similar pattern runs in the family.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and on the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside the rest of a person’s care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, it can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person but less well for another, or why some people are more likely to notice side effects. Small differences in genes can change how the body breaks down, transports, or responds to a drug. These differences are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies gene-drug relationships to clarify why the same treatment can work differently in different people. With many medications, genes influence both how powerful a drug’s effects are and how the body handles it. This information can support more informed, personalized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the KDM3B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. Questions about side effects, new symptoms, or how medicines fit with your overall health are best discussed with your doctor.
History
KDM3B entered the research literature in the 2000s, during a period when scientists were redefining how genes are switched on and off. Initially understood through its similarity to related genes, it was later recognized as part of a broader group involved in epigenetic control, meaning chemical signals that influence gene activity. From these first observations, research expanded steadily. Studies then linked the KDM3B gene to chromosome region 5q, an area of long standing interest in blood cancer research. This helped move KDM3B from a basic science finding into clinical genetics discussions. Over time, its place in cancer biology and inherited cell regulation became clearer.